134 related articles for article (PubMed ID: 34797440)
21. Does three-dimensional surgery affect recurrence patterns in patients with gastric cancer after laparoscopic R0 gastrectomy? Results from a 3-year follow-up phase III trial.
Lu J; Xu BB; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Zheng CH; Huang CM; Li P
Surg Endosc; 2021 Jan; 35(1):113-123. PubMed ID: 31953725
[TBL] [Abstract][Full Text] [Related]
22. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.
Arima K; Hashimoto D; Okabe H; Inoue R; Kaida T; Higashi T; Taki K; Nitta H; Hayashi H; Chikamoto A; Beppu T; Baba H
Surg Today; 2016 Jul; 46(7):792-7. PubMed ID: 26302976
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Intraoperative Blood Loss on the Survival After Laparoscopic Surgery for Colorectal Cancer.
Shibutani M; Maeda K; Kashiwagi S; Hirakawa K; Ohira M
Anticancer Res; 2021 Sep; 41(9):4529-4534. PubMed ID: 34475079
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer.
Kamei T; Kitayama J; Yamashita H; Nagawa H
World J Surg; 2009 Jun; 33(6):1240-6. PubMed ID: 19308640
[TBL] [Abstract][Full Text] [Related]
26. D2 gastrectomy with versus without bursectomy for gastric cancer.
Kochi M; Fujii M; Kanamori N; Kaiga T; Mihara Y; Funada T; Tamegai H; Takayama Y; Yoshida N; Takayama T
Am J Clin Oncol; 2014 Jun; 37(3):222-6. PubMed ID: 22892432
[TBL] [Abstract][Full Text] [Related]
27. Effect of obesity on intraoperative bleeding volume in open gastrectomy with D2 lymph-node dissection for gastric cancer.
Makino H; Kunisaki C; Akiyama H; Ono HA; Kosaka T; Takagawa R; Nagano Y; Fujii S; Shimada H
Patient Saf Surg; 2008 Apr; 2():7. PubMed ID: 18435844
[TBL] [Abstract][Full Text] [Related]
28. Short- and Long-Term Outcomes in Malnourished Patients After Laparoscopic or Open Radical Gastrectomy.
Zheng HL; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Tu RH; Huang CM
World J Surg; 2018 Jan; 42(1):195-203. PubMed ID: 28741200
[TBL] [Abstract][Full Text] [Related]
29. Blood loss and outcomes after resection of colorectal liver metastases.
Margonis GA; Kim Y; Samaha M; Buettner S; Sasaki K; Gani F; Amini N; Pawlik TM
J Surg Res; 2016 May; 202(2):473-80. PubMed ID: 27038662
[TBL] [Abstract][Full Text] [Related]
30. Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly.
Kunisaki C; Sato S; Tsuchiya N; Kubo H; Watanabe J; Sato T; Takeda K; Tamura Y; Kasahara K; Kosaka T; Akiyama H; Endo I
Eur Surg Res; 2021; 62(1):40-52. PubMed ID: 33794520
[TBL] [Abstract][Full Text] [Related]
31. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
[TBL] [Abstract][Full Text] [Related]
32. Postoperative Prolonged Inflammatory Response as a Poor Prognostic Factor After Curative Resection for Gastric Cancer.
Okumura Y; Hiki N; Kumagai K; Ida S; Nunobe S; Ohashi M; Sano T
World J Surg; 2017 Oct; 41(10):2611-2618. PubMed ID: 28451762
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of infectious complications after curative gastric cancer surgery.
Han WH; Oh YJ; Eom BW; Yoon HM; Kim YW; Ryu KW
Eur J Surg Oncol; 2020 Jul; 46(7):1233-1238. PubMed ID: 32362466
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
[TBL] [Abstract][Full Text] [Related]
36. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
37. Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.
Zhang WH; Chen XZ; Yang K; Liu K; Chen ZX; Zhang B; Zhou ZG; Hu JK
World J Surg Oncol; 2015 Dec; 13():332. PubMed ID: 26643472
[TBL] [Abstract][Full Text] [Related]
38. Impact of intraoperative blood loss on morbidity and survival after radical surgery for colorectal cancer patients aged 80 years or older.
Okamura R; Hida K; Hasegawa S; Sakai Y; Hamada M; Yasui M; Hinoi T; Watanabe M;
Int J Colorectal Dis; 2016 Feb; 31(2):327-34. PubMed ID: 26412248
[TBL] [Abstract][Full Text] [Related]
39. Operative safety of curative gastrectomy after endoscopic submucosal dissection (ESD) for early gastric cancer - 1:2 propensity score matching analysis: A retrospective single-center study (cohort study).
Park KB; Jeon CH; Seo HS; Jung YJ; Song KY; Park CH; Lee HH
Int J Surg; 2020 Aug; 80():124-128. PubMed ID: 32622936
[TBL] [Abstract][Full Text] [Related]
40. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.
Sakar B; Karagol H; Gumus M; Basaran M; Kaytan E; Argon A; Ustuner Z; Bavbek SE; Bugra D; Aykan FN
Am J Clin Oncol; 2004 Apr; 27(2):205-9. PubMed ID: 15057162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
